Researchers at the University of Alberta are studying whether combining a commercially available wearable device with artificial intelligence can effectively predict symptom worsening in people with chronic lung conditions, such as idiopathic pulmonary fibrosis (IPF).

Developed by New York-based Health Care Originals to monitor asthma, the ADAMM-RSM is a small, flexible, and comfortable patch-like device that can be attached to the side, front, or back of the upper torso under clothing.

Read Full Article Here >

Recent Posts